This is a slightly edited version of a personal message to me from Professor Cedric Garland about the NICE & NHS decision to offer Tamoxifen or Raloxifene to UK women who may have a higher than average risk of Breast Cancer:
“This is a great example of an organization selecting the a completely wrong solution to a problem.
It must be this approach that the big breast cancer organizations have in mind when they mention eradication of breast cancer by 2020.
This is probably driven mainly by Big Pharma who stand to make billions from patented drugs that people have to take every day to prevent a disease, even if they cause other diseases. If their aproach is used, it will be an empty promise by 2020 or any year.
If anyone could send me any citations they may have seen touting the efficacy of Tamoxifen or Raloxifene in preventing breast cancer, I’d love to read them.
Since very big money is involved, these two risky drugs will be the well-funded competition against vitamin D in the field of breast cancer prevention.
Without concerned scientists, physicians and engineers, such as members of the international vitamin D scientific and clinical community, Big Pharma exceutives would win this battle and the people would lose.
Professor of Public Health
University of California at San Diego
If anyone would like to send comments directly to me I will be pleased to forward them to Professor Garland
You can read more about his work with Vitamin D at: http://grassrootshealth.net/
Learn more about Vitamin D and Breast Cancer at: